AVRO News and Press, AVROBIO Inc.

2024-06-20 16:54:42 ET More on AVROBIO Historical earnings data for AVROBIO Financial information for AVROBIO Read the full article on Seeking Alpha For further details see: Tectonic, AVROBIO complete merger, announce $130.7M private placement

2024-06-20 09:02:05 ET AvroBio Inc (AVRO) announced stock split at a ratio of 1-for-12 on 2024-06-21 ... Full story available on KlickAnalytics.com

2024-06-03 16:24:14 ET More on AVROBIO Seeking Alpha’s Quant Rating on AVROBIO Historical earnings data for AVROBIO Financial information for AVROBIO Read the full article on Seeking Alpha For further details see: Tectonic Therapeutic appoi...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...

NEW YORK, NY / ACCESSWIRE / February 27, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Chord Energy Corporation (NASDAQ: CH...

NEW YORK, NY / ACCESSWIRE / February 16, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: PGT Innovations, Inc. (NYSE:PGTI)'s ...

NEW YORK, NY / ACCESSWIRE / February 1, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: AVROBIO, Inc. (NASDAQ:AVRO)'s merge...

2024-01-30 08:32:50 ET More on AVROBIO Seeking Alpha’s Quant Rating on AVROBIO Historical earnings data for AVROBIO Financial information for AVROBIO Read the full article on Seeking Alpha For further details see: Avrobio to buy 100% equity...

Combined company to be Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Tectonic’s novel GPCR-targeted therapeutic proteins $130.7 million in private financing commitments with new and existing leading life sciences investors in connection with merger ...